Connecting YOU to the Alliance Wendy Schettler and Tanya Merke Epp Alliance Coordinating Office, International Centre for Infectious Diseases

Canadian HIV Vaccine Initiative (CHVI) CHVI Research and Development Alliance (Alliance) & its supporting Alliance Coordinating Office (ACO) Opportunities for Participation in the Alliance Overview of the Alliance Virtual Community (Alliance VC) Outline

Canada's contribution to the Global HIV Vaccine Enterprise Partnership between Government of Canada (CIDA, CIHR, IC, PHAC, HC) and the Bill and Melinda Gates Foundation Began 2007, renewal 2010,operating until 2017 $139,000,000 initiative with approximately ¾ of dollars designated CHVI

The CHVI Alliance is a Canadian network that brings together leading researchers from the public and private sectors, as well as the international community, to develop innovative solutions to the challenges facing HIV vaccine development. The Alliance Coordinating Office (ACO) supports the Alliance and the Advisory Board, focusing on building and sustaining the Alliance, advising the Government of Canada and the Bill & Melinda Gates Foundation on research gaps, prospecting innovative proposals to respond to identified gaps and promoting synergy among Alliance members. CHVI Secretariat Bill & Melinda Gates Foundation President, Global Health Minister of Health (Lead) Minister of International Cooperation Minister of Industry Advisory Board CHVI Research and Development Alliance Canadian HIV Researchers Vaccine Industry Government Agencies Intl AIDS Organizations Alliance Coordinating Office HIV/AIDS Community Organizations International Researchers CHVI ALLIANCE CHVI - Canadas Contribution to HIV Vaccine Development

Guiding Framework: Key considerations Strategic priorities and investments of Alliance funders Strategic priorities and investments of global research organizations Energy, aspirations and contribution of the Canadian research community Canadas focus and goals

Canadas Niche Generate and apply population-level knowledge to drive vaccine discovery and development Strengthen linkages to understand mechanisms of immunity Leverage preclinical resources to test vaccine concepts Priority 1 Harness Canadas excellence in basic science and strengthen linkages with clinical research, social sciences and people living with HIV/AIDS, as well as with vaccine researchers outside the HIV field Priority 2 Amplify Canadas strengths in clinical research, community engagement and capacity- building globally and nationally Improve clinical trial and regulatory capacity in Canada and globally through community engagement Engage communities, researchers and policy- makers in clinical trial and vaccine preparedness Test HIV vaccine candidates in Canada Guiding Framework for the CHVI Alliance

Priority 3 Accelerate the translation of Canadas scientific discoveries Create opportunities to engage industry in advancing vaccine concepts Support researchers and companies in accessing GMP manufacturing capacity Ensure Canadian and global regulators are engaged to accelerate clinical development Priority 4 Strengthen and enable new and early-career investigators Integrate new investigators into the larger national/global HIV vaccine effort Increase training in clinical trials and population / epidemiological research Enrich training of researchers from Canada and developing countries Enablers Guiding Framework for the CHVI Alliance (continued)

Championing and enabling Canadas contribution to global HIV vaccine efforts Brokering collaboration among stakeholders Communication and awareness-building to advance ongoing HIV vaccine efforts Facilitating translation, commercialization and industry outreach Developing new and early-career investigators Priority Areas for CHVI Alliance Support by the ACO

White Paper Priorities Basic ScienceClinical TrialsTranslationNew Investigators ACO Priorities Championing Setting Strategic Direction Immunology Lab – South Africa CTN / HVTN clade B vaccine trial - plans AVAREF Support Small medium size business grants Collaboration Building the CHVI Alliance CIHR connection with BGMF Participation in CIHR large team grant meeting Synchronicity Forum with CAPT Network using VC Phase II b clinical trial discussion GeoVax/CTN IC connection with BGMF Landscape document on research and training Communication Linking & informing Annual Meeting, Advisory Board Meetings, Brokering Meetings, Virtual Community Website, E-Bulletin, Contact Lists, Research Database, Conference Booths, Social Media Advisory Board Support, White Paper, Presentations, Surveys, News Releases, Planning Conferences ACO Priority Activities

White Paper Priorities Basic ScienceClinical TrialsTranslationNew Investigators ACO Priorities Translation, commercialization and industry outreach Developing new and early-career investigators Virtual Community Webinars Collaboration E-bulletin Landscape document Student scholarships ACO Priority Activities Monoclonal Antibodies production; Participation in Vaccine Industry Committee, Biotech Canada Presentations and outreach, Advisory Board support ACO Annual Meeting Focus on linking industry and public research

New and Early Career Investigators Webinars & Workshops Network Communicate Share Expertise Use ACO Resources Opportunities

Website:alliance-aco.ca Subscribe to the ACO E-Bulletin Facebook: Alliance Coordinating Office To Connect With Us - Find Us Online

Connecting You to the Alliance: A virtual community for HIV vaccine research and development CHVI R&D Alliance Virtual Community (Alliance VC)

1. What is a Virtual Community? 2. Why YOU should belong? 3. How to access the Virtual Community? Presentation Objectives

Communities of Practice (CoP) are: groups of people who share a concern, a set of problems, or a passion about a topic, and who deepen their knowledge and expertise in this area by interacting on an on-going basis (Wenger, McDermott, & Snyder, 2002, p.4). Virtual Communities of Practice (VCoP), without excluding F2F rely primarily on Information and Communication Technologies (ICT) to connect their members What is a Virtual Community?

The Canadian HIV Vaccine Initiative (CHVI) Research and Development Alliance Virtual Community (Alliance VC) is a confidential internet-based community designed for researchers to collaborate, communicate and share research and to seek information about Canadas contribution to the global development of an HIV vaccine. CHVI R&D Alliance Virtual Community (Alliance VC)

The Alliance VC will help you: Stay informed about updates in the field Communicate with your peers Collaborate in private committees Engage in online learning opportunities Why Participate?

FREE!!! A virtual meeting space for collaborations Hosting of confidential interest or project groups An online collaborative document creation and editing tool Training webinars and web conferencing capabilities Discussion forums Resource materials A Canadian researcher database CHVI R&D Alliance Virtual Community (Alliance VC)

Confidential and secure space for your teams, committees or working groups

Committee Tool - Members View and message individual members of the committee

Committee Tool – Meeting Planner Schedule meetings with the planner

Committee Tool – Meetings Manage and view events Add meeting dates to your Outlook or Google Calendar

Committee Tool – Meeting Agendas Manage your meeting agendas

Committee Tool – Files Manage your committee files

Committee Tool – Wiki Collaborative write documents in real time

Committee Tool – Forums Committee discussion forum

Web conferencing allows you to hold meetings, events, or classes in real-time over the Internet using Voice-over- the-Internet (VoIP). All you need to participate in a Web conference is a headset with a microphone. CHVI R&D Alliance Virtual Community (Alliance VC)

Web Conferencing features include: Recording. Desktop sharing. Voice conferencing. Upload document and presentations. Webcam use. Whiteboard tools. Web Conferencing

CHVI R&D Alliance Virtual Community (Alliance VC)

Discussion Forums Introductions Forum News Forum Early Career Investigator Forum

CHVI R&D Alliance Virtual Community (Alliance VC)

Resources

CHVI R&D Alliance Virtual Community (Alliance VC)

The Alliance VC will help you: Stay informed about updates in the field Communicate with your peers Collaborate in private committees Engage in online learning opportunities Why Participate?

Easy way to collaborate and communicate with members of the CHVI R&D Alliance Secure environment where private committees and teams can plan events and meetings, store and view documents, and use private discussion forums Retrieve files and documents from anywhere you have Internet access Collaboratively write in real time Receive important and up-to-date information and news related to HIV vaccine development Coordinate Web Conferences for free Key Features of the Alliance VC

Abstract reviews completed and results report created Repository of capacity building documents is in development Plan meetings Documents are accessible anywhere you have Internet access Discussion forums Career and training opportunities Web conferences Evaluation questionnaire and results report Current Uses of the Alliance VC

Communicate with your peers Ask questions Seek advice Share exciting developments Advertise career opportunities Share expertise with New/Early Career Investigators Message members or the entire community Collaborate Write a grant in a secure environment Engage in online learning opportunities Other ways to use the Alliance VC

1. Go to the Alliance Coordinating Office website anytime and click on the Login button 2. Small group demonstrations 3. One-on-one demonstrations 4. How to register

Website:alliance-aco.ca Subscribe to the ACO E-Bulletin Facebook: Alliance Coordinating Office To Connect With Us - Find Us Online